Skip to main content
. Author manuscript; available in PMC: 2013 Aug 15.
Published in final edited form as: Am J Cardiol. 2012 May 12;110(4):539–544. doi: 10.1016/j.amjcard.2012.04.027

Table 3.

Odds ratios for coronary heart disease by quintiles or per standard deviation increase of red blood cell membrane cis- vaccenic fatty acids in the Physicians’ Health Study

Quintiles [Range] of cis- vaccenic acid (18:1n-7) Cases Odds ratio (95% CI) for coronary heart disease
Model 1* Model 2
Q1 (low) [0.90–1.49] 233 1.0 1.0
Q2 [1.50–1.68] 191 0.76 (0.56–1.02) 0.75 (0.55–1.03)
Q3 [1.69–1.92] 208 0.74 (0.54–1.03) 0.66 (0.47–0.94)
Q4 [1.93–2.53] 175 0.60 (0.42–0.85) 0.55 (0.38–0.81)
Q5 (high) [>2.54] 193 0.59 (0.40–0.88) 0.56 (0.37–0.85)
P for trend 0.01 0.007

Per SD increase of log-vaccenic acid (cis 18:1n-7) 0.80 (0.70–0.91) 0.79 (0.69–0.91)
*

Model 1 adjusted for matching variables and cis-palmitoleic acid; SD=standard deviation of log-transformed red blood cell membrane cis- palmitoleic acid

Model 2 adjusted for matching variables plus body mass index, prevalent hypertension, hypercholesterolemia, atrial fibrillation, diabetes, left ventricular hypertrophy, smoking, alcohol intake, physical activity, and red blood cell membrane 18:0, 16:0, and marine omega-3 fatty acids (20:5n-3, 22:5n-3, and 22:6n-3)

Fatty acids expressed as percentage of total red blood cell membrane fatty acids